New computer simulation offers insights into brain function

A new computer simulation of how our brains develop and grow neurons has been built by scientists from the University of Surrey.

Arrowhead reports full Phase 2b data for lipid drug, but Ionis is a step ahead: #ACC24

Five months after Arrowhead Pharmaceuticals unveiled topline results for its Phase 2b RNAi candidate in a lipid-related disease, the company on Sunday reported full data

April 8, 2024

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

Individuals screened for Epstein-Barr virus (EBV) infection had a significantly lower risk of nasopharyngeal cancer (NPC) mortality, a large randomized study from China showed. Screened

October 5, 2024

Hydrofarm Q2 Revenue Increases 1% From Q1

Hydrofarm Holdings Group Announces Second Quarter 2023 Results Shoemakersville, PA — August 9, 2023 — Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM),

August 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.